DR. EBRAHIM S DELPASSAND, M.D.
Radiology at Richmond Ave, Houston, TX
License number
Texas H8621
Category
Radiology
Type
Nuclear Radiology
Address
Address
9701 Richmond Ave SUITE 122, Houston, TX 77042
Phone
(713) 781-6200
(713) 781-6206 (Fax)
(713) 781-6206 (Fax)
Personal information
See more information about EBRAHIM S DELPASSAND at radaris.comName
Address
Phone
2115 River Oaks Blvd, Houston, TX 77019
22 Pin Oak Estates Ct, Bellaire, TX 77401
2115 River Oaks Blvd, Houston, TX 77019
22 Pin Oak Estates Dr, Bellaire, TX 77401
PO Box 300048, Houston, TX 77230
Organization information
See more information about EBRAHIM S DELPASSAND at bizstanding.comExcel Diagnostics - Ebrahim S Delpassand MD
9701 Richmond Ave STE 122, Houston, TX 77042
Categories:
Radiology Physicians & Surgeons
Phone:
(713) 781-6200 (Phone)
Professional information
Dr. Ebrahim S Delpassand, Houston TX - MD (Doctor of Medicine)
Specialties:
Nuclear Medicine, Nuclear Radiology, Radiation Oncology
Address:
9701 Richmond Ave SUITE 122, Houston 77042
(713) 781-6200 (Phone), (713) 781-6206 (Fax)
(713) 781-6200 (Phone), (713) 781-6206 (Fax)
Procedures:
Nuclear Medicine, Pet Scan, Radiology-Diagnostic
Conditions:
Cancers-Prostate Cancer, Gastro-Enteropancreatic Neuroendocrine Tumor, Metastatic Bone Cancer, Thyroid Cancer
Certifications:
Nuclear Medicine, 1990
Awards:
Healthgrades Honor Roll
Languages:
English, Farsi
Hospitals:
9701 Richmond Ave SUITE 122, Houston 77042
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
St. Luke's Medical Center
6720 Bertner Ave, Houston 77030
Philosophy:
Personalized patient care and understanding that each patient is different while they might have similar disease.
Education:
Medical School
Iran University Of Medical Sciences / Faculty Of Medicine
Graduated: 1981
Tehran U Hosps
Graduated: 1982
Tehran U Med Sch
Graduated: 1977
Iran University Of Medical Sciences / Faculty Of Medicine
Graduated: 1981
Tehran U Hosps
Graduated: 1982
Tehran U Med Sch
Graduated: 1977
Ebrahim S Delpassand, Houston TX
Specialties:
Nuclear Medicine, Pathology, Anatomic Pathology, Anatomic Pathology & Clinical Pathology, Nuclear Radiology
Work:
Excel Diagnostic Imaging Clini.
9701 Richmond Ave, Houston, TX 77042 M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
9701 Richmond Ave, Houston, TX 77042 M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
Education:
Tehran School Of Medical Sciences (1982)
High Dose 111In-Pentetreotide Therapy Of Neuroendocrine Tumors
US Patent:
2008024, Oct 9, 2008
Filed:
Apr 6, 2007
Appl. No.:
11/784251
Inventors:
Ebrahim S. Delpassand - Houston TX, US
International Classification:
A61K 51/08
US Classification:
424 169
Abstract:
A method for treating a neuroendocrine tumor is disclosed, which includes administering a first dose of In-pentetreotide to a subject having the neuroendocrine tumor; and administering a second dose of In-pentetreotide to the subject after a selected duration has elapsed after the administering of the first dose, wherein the first dose and the second dose are each about 400 mCi or higher, and wherein the selected duration is at least a week. In another method, the first dose and the second dose are each about 500 mCi and the selected duration is between 10 and 12 weeks. The method may further include administration of a third dose. A composition for treating a neuroendocrine tumor includes In-pentetreotide having a radioactivity of about 400 mCi or higher in a single dose.
Ebrahim S Delpassand, Houston TX
Specialties:
Nuclear Medicine Specialist
Address:
9701 Richmond Ave, Houston, TX 77042
5420 West Loop S, Bellaire, TX 77401
5420 West Loop S, Bellaire, TX 77401
Education:
Tehran University of Medical Sciences - Doctor of Medicine*
Baylor Clinic & Hospital - Residency - Pathology*
Baylor Clinic & Hospital - Residency - Nuclear Medicine*
Tehran University of Medical Sciences - Internship - Transitional Year*
Baylor Clinic & Hospital - Residency - Pathology*
Baylor Clinic & Hospital - Residency - Nuclear Medicine*
Tehran University of Medical Sciences - Internship - Transitional Year*
Board certifications:
American Board of Nuclear Medicine Certification in Nuclear Medicine*
Compositions For Targeted Imaging And Therapy
US Patent:
2009008, Apr 2, 2009
Filed:
Mar 27, 2008
Appl. No.:
12/057066
Inventors:
Ali Azhdarinia - Houston TX, US
Ebrahim S. Delpassand - Houston TX, US
Izabela Tworowska - Houston TX, US
Ebrahim S. Delpassand - Houston TX, US
Izabela Tworowska - Houston TX, US
International Classification:
A61K 51/04, A61K 103/00, A61K 103/10, A61K 103/40, A61K 103/20, A61K 103/34, A61K 103/32, A61K 49/10, A61K 47/48
US Classification:
424 165, 424 9364, 514788
Abstract:
The present invention relates to the field of radiochemistry, nuclear imaging, radionuclide therapy and chemical synthesis. More particularly, it concerns a strategy for radiolabeling target ligands. It further concerns methods of using those radiolabeled ligands for imaging, radionuclide therapy and tissue-specific disease imaging.